About
INVO Bioscience, based in Sarasota, Florida, is a healthcare company focused on fertility treatments and assisted reproductive technology. Founded in 2007, the company aims to make fertility care more accessible and affordable worldwide. Its flagship product, the INVOcell device, is an intravaginal culture system that allows fertilization and early embryo development to occur naturally within the woman's body, providing an alternative to traditional in vitro fertilization (IVF). The company operates through several segments, including fertility clinic services with INVO Centers, sales of the INVOcell device, and the development of novel therapeutics. INVO Bioscience has established a licensing agreement with Ferring Pharmaceuticals, enhancing its market presence. In 2025, the company merged with NAYA Biosciences, expanding its portfolio to include oncology and autoimmune therapeutics. INVO Bioscience is dedicated to addressing the needs of infertile couples and improving reproductive healthcare through innovative solutions.
Technologies
Keywords
Company Information
-
Employees 25
-
Founded 2009
-
Annual Revenue $8167608000
-
Total Funding $6605000
Location
5582 Broadcast Ct, Sarasota, Florida, United States, 34240
